Gabelli Funds’s Allergan plc AGN.PRA Stock Holding History

Gabelli Funds’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,800	Closed	-$1.64M	–	1170
2017 Q4	$1.64M	Buy	+2,800	New	+$1.81M	0.01%	819
2017 Q3	–	Sell	-4,000	Closed	-$3.47M	–	1137
2017 Q2	$3.47M	Hold	4,000	–	–	0.02%	649
2017 Q1	$3.39M	Buy	4,000 +1,250	+45%	+$1.04M	0.02%	654
2016 Q4	$2.1M	Sell	2,750 -4,550	-62%	-$3.44M	0.01%	773
2016 Q3	$6M	Hold	7,300	–	–	0.04%	501
2016 Q2	$6.08M	Buy	7,300 +700	+11%	+$585K	0.04%	494
2016 Q1	$6.07M	Buy	6,600 +2,000	+43%	+$1.91M	0.04%	491
2015 Q4	$4.73M	Buy	+4,600	New	+$4.62M	0.03%	559

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Gabelli Funds's AGN.PRA Position: Q1 2018 in Review

Gabelli Funds sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 2,800 shares — an estimated $1.64M sold.

Gabelli Funds first reported a position in AGN.PRA in Q4 2015 and held it in 8 quarters. The position peaked at $6.08M in Q2 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Gabelli Funds reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Gabelli Funds sold 2,800 Allergan plc shares in Q1 2018, an estimated $1.64M.
Gabelli Funds first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
Gabelli Funds's Allergan plc position peaked at $6.08M in Q2 2016.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Gabelli Funds's 13F filing for Q1 2018, filed 9 May 2018.